Bit Capital Gmb H Coherus Bio Sciences, Inc. Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Feb 12, 2025	SELL	$0.99 - $1.8 $830,557 - $1.51 Million	-838,947 Closed	0 $0
Q2 2024 Feb 12, 2025	SELL	$1.58 - $2.51 $32,886 - $52,243	-20,814 Reduced 2.42%	838,947 $1.45 Billion
Q1 2024 Feb 12, 2025	BUY	$2.02 - $3.14 $1.36 Million - $2.11 Million	671,829 Added 357.49%	859,761 $2.05 Billion
Q4 2023 Feb 12, 2025	BUY	$1.59 - $3.85 $268,601 - $650,388	168,932 Added 889.12%	187,932 $626 Million
Q3 2023 Feb 12, 2025	BUY	$3.74 - $5.45 $71,060 - $103,550	19,000 New	19,000 $71.1 Million

133

73.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $86.3M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.